|
|
See Category: Diseases of the musculoskeletal system and connective tissue
ICD-10 (CM) Code and Descriptor
|
M05.9 |
Rheumatoid arthritis with rheumatoid factor, unspecified
|
M059 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 62.54%
|
13.24%
|
7.69%
|
5.01%
|
3.37%
|
2.31%
|
1.64%
|
1.15%
|
0.88%
|
0.61%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M05.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
24,258
|
24,263
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
22,356
|
22,396
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
20,661
|
20,686
|
|
80053
|
COMPREHEN METABOLIC PANEL |
18,563
|
18,563
|
|
86140
|
C-REACTIVE PROTEIN |
18,342
|
18,342
|
|
85652
|
RBC SED RATE AUTOMATED |
14,205
|
14,205
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
8,326
|
8,334
|
|
82565
|
ASSAY OF CREATININE |
7,876
|
7,876
|
|
96413
|
CHEMO IV INFUSION 1 HR |
7,640
|
7,790
|
|
J0129
|
ABATACEPT INJECTION |
6,231
|
469,427
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
5,478
|
5,822
|
|
84460
|
ALANINE AMINO (ALT) (SGPT) |
5,043
|
5,043
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
4,419
|
7,036
|
|
84450
|
TRANSFERASE (AST) (SGOT) |
4,332
|
4,332
|
|
80076
|
HEPATIC FUNCTION PANEL |
4,226
|
4,226
|
|
85651
|
RBC SED RATE NONAUTOMATED |
4,220
|
4,220
|
|
J3262
|
TOCILIZUMAB INJECTION |
3,816
|
1,165,377
|
|
85027
|
COMPLETE CBC AUTOMATED |
3,439
|
3,442
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
2,997
|
3,752
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
2,914
|
123,501
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M05.9 related to the following DRG Codes:
545-547
|
